2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Anterior Cruciate Ligament Injuries
1
Interventions
pembrolizumab
1262
Specimen Handling
924
Magnetic Resonance Spectroscopy
829
Carboplatin
821
Cyclophosphamide
799
Cisplatin
722
Nivolumab
667
Paclitaxel
627
Radiotherapy
608
Gemcitabine
570
Biopsy
557
Bevacizumab
478
Dexamethasone
437
fludarabine
407
Docetaxel
377
venetoclax
367
Oxaliplatin
364
Capecitabine
355
Fluorouracil
355
atezolizumab
350
durvalumab
332
Rituximab
329
Drug Therapy
325
Doxorubicin
316
Radiosurgery
314
Standard of Care
309
Blood Specimen Collection
308
Pemetrexed
304
Ipilimumab
298
Radiation
285
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
ATP Citrate (pro-S)-Lyase
×
1 year
×
Clear all
NCT07451743
2026-03-05
ACL ALL
ASL Lecce
Phase NA
Not yet recruiting
100 enrolled